← Leaderboards
Nejat A Duzgunes
University Of California San Francisco
$19,760
Attributed
$19,760
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$19,760 · 2
By mechanism
P41$19,760 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Alma L Burlingame$22,822,480
- Diane W. Wara$7,985,315
- Paul A Volberding$41,854,974
- Mallory O Johnson$32,174,181
- George W Rutherford$77,244,891
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusInflammationLymphatic SystemSpectrometryStructural BiologyAidsBiological ProductsBiomedical ResourceImmunologyInfectionBacteriaOral PharyngealProteinsDrug /AgentRespiratory System
Grant awards (6)
DRUG TARGETING TO HIV INFECTED CELLS$0
P41 · FY2002 · RR
HIV INHIBITORY ACTION &STRUCT OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI)$0
P41 · FY2002 · RR
DRUG TARGETING TO HIV INFECTED CELLS$0
P41 · FY2001 · RR
HIV INHIBITORY ACTION &STRUCT OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI)$0
P41 · FY2001 · RR
DRUG TARGETING TO HIV INFECTED CELLS$9,880
P41 · FY2000 · RR
HIV INHIBITORY ACTION &STRUCT OF SECRETORY LEUKOCYTE PROTEASE INHIBITOR (SLPI)$9,880
P41 · FY2000 · RR